Radius Health (NASDAQ: RDUS)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-07 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.030 | -0.270 | -0.3000 | ||||
REV | 58.285M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Radius Health (NASDAQ: RDUS) through any online brokerage.
There are no as such competitors for Radius Health.
The latest price target for Radius Health (NASDAQ: RDUS) was reported by SVB Leerink on Friday, June 24, 2022. The analyst firm set a price target for 10.00 expecting RDUS to fall to within 12 months (a possible -0.79% downside). 13 analyst firms have reported ratings in the last year.
The stock price for Radius Health (NASDAQ: RDUS) is $10.08 last updated August 12, 2022, 8:00 PM UTC.
There are no upcoming dividends for Radius Health.
Radius Health’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Radius Health.
Radius Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.